MHRA Women’s Health Programme 2026-2030
The Women’s Health Programme supports better evidence and regulation of medicines and medical devices to improve health outcomes for women.
Documents
Details
Our Strategy to 2030 sets out how to deliver health and prosperity for all, through scientific excellence. One of our strategic priorities within this strategy is to deliver proactive regulation to address evidence gaps and reduce inequalities.
Our Women’s Health Programme 2026 to 2030 supports work to improve the safety and effectiveness of medicines and medical devices used by women, and to ensure women’s needs are better reflected in healthcare research and regulation.